Archives for May 21, 2021

← 2021

Positive interim Phase 2 results for COVID-19 vaccine from Medicago and GSK

21-May-2021

By Jane Byrne

Canadian biotechnology company, Medicago, announced positive interim Phase 2 results this week for its plant-derived COVID-19 vaccine, which has been tested in combination with GSK’s pandemic adjuvant.

Gamma Biosiences takes majority stake in Mirus Bio

21-May-2021

By Jane Byrne

Gamma Biosciences has taken a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Wisconsin in the US.